The 3D cell culture industry is poised for substantial growth from 2025 to 2035, driven by advancements in biotechnology and ...

NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) ("NurExone" or the "Company") is pleased to announce the formation of a U.S.-based ...

The biologics drug substance manufacturing market is witnessing substantial expansion, largely due to the growing prevalence of chronic disea ...

Exo-Top was established under the jurisdiction of the State of Nevada. Basing Exo-Top in the U.S. offers key advantages, including proximity to strategic partners, access to a robust biopharma ...

SHANGHAI, China I 5, 2025 I Shanghai Henlius Biotech, Inc. (2696.HK) announced that its anti-PD-1 mAb, HANSIZHUANG (serplulimab, marketed as ...

Please also check out our list of U.S. inverter manufacturing locations and our list of U.S. mounting manufacturers. Use the tabs above to view different groupings. *Some Made-in-America brands ...

A national conference on ‘Enhancing Pharmaceutical Quality Assurance through Good Manufacturing Practices’ was organised by the Department of Pharmaceuticals, Ministry of Chemicals and ...

In this first of a four-part series, the authors provide an introduction to a practical approach for establishing specification equivalence. The regulatory basis and compliance examples from FDA ...

After an inspection conducted between June 12 and July 9, 2024 the agency flagged major concerns about the facility’s processes for producing active pharmaceutical ingredients, or APIs.

21, 2025 (GLOBE NEWSWIRE) -- Nacuity Pharmaceuticals ... NPI-001 is a proprietary, GMP-grade formulation of N-acetylcysteine amide (NACA) tablets being developed to target oxidative stress ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator.